Table of Contents Author Guidelines Submit a Manuscript
Psychiatry Journal
Volume 2014 (2014), Article ID 730956, 6 pages
Review Article

The Potential Utility of Pharmacogenetic Testing in Psychiatry

Genomind, Inc., 2200 Renaissance Boulevard, Suite 100, King of Prussia, PA 19406, USA

Received 29 September 2014; Accepted 23 November 2014; Published 17 December 2014

Academic Editor: Andrzej Pilc

Copyright © 2014 Kathryn R. Gardner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Over the last decade, pharmacogenetics has become increasingly significant to clinical practice. Psychiatric patients, in particular, may benefit from pharmacogenetic testing as many of the psychotropic medications prescribed in practice lead to varied response rates and a wide range of side effects. The use of pharmacogenetic testing can help tailor psychotropic treatment and inform personalized treatment plans with the highest likelihood of success. Recently, many studies have been published demonstrating improved patient outcomes and decreased healthcare costs for psychiatric patients who utilize genetic testing. This review will describe evidence supporting the clinical utility of genetic testing in psychiatry, present several case studies to demonstrate use in everyday practice, and explore current patient and clinician opinions of genetic testing.